between pediatric donors and adult recipients, the PTA strategy limits the use of kidneys from pediatric donors, especially low-weight ones, resulting in more size mismatches, en bloc transplants, and kidney environment changes, which may explain the high rate of complications that has been observed. Therefore, our center selected pediatric recipients and characterized the feasibility and efficacy of the PTP allocation strategy. Grafts are used for en bloc RTx if the donor weighs 2.5-5 kg, and grafts are used for single-kidney transplantation if the donor weighs 5-15 kg. 6 Consequently, the growth after RTx in our center has notably improved. Therefore, in this study,
we retrospectively analyzed the outcomes of growth after RTx using the PTP allocation strategy and some factors that may affect it.
| PATIENTS AND ME THODS
The retrospective study design was approved by the appropriate ethics review board.
| Patients
From March 2012 to August 2016, we successfully performed 38 single-kidney transplantations and 8 en bloc transplantations; the patient population included 21 male patients and 25 female patients. Graft thrombosis occurred in four recipients of EBKT within 1 week after transplantation, and these recipients were excluded from this study. Twenty-four children who had been followed up for more than 3 years, 16 for 2 years, and 6 for 1 year and had not been treated with rhGH were included in this study.
| Methods
We retrospectively collected data of recipients' sex, age, history of dialysis before RTx, and children's height and serum creatinine levels at 12-month interval after RTx. Height was determined using the average of three measurements obtained using an electronic ruler.
The GFR was estimated using the Schwartz formula. 7 The growth of children was assessed by HAZ, which was derived as follows: HAZ = [(patient's height) − (height at the 50th percentile for age and sex)/(standard deviation of height for age and sex)].
When the HAZ was <−2, the child was considered to have experienced growth retardation, whereas catch-up growth was defined as a change in HAZ (ΔHAZ > 0.5).
| Immunosuppression
Basiliximab or thymoglobulin was administered as induction therapy.
Intravenous methylprednisolone was initiated intraoperatively at an initial dose of 10 mg/kg/day, and then, it was gradually tapered off in the first week after RTx. Maintenance immunosuppression involved administration of tacrolimus (0.15 mg/kg/dose twice daily) and enteric-coated mycophenolate sodium (540 mg/m 2 /day across two doses per day).
| Statistical analysis
Results are presented as mean ± SD, median, and range for continu- 
| RE SULTS
We retrospectively collected data and analyzed the results of 46 pediatric procedures ( postoperatively, respectively. Twenty-five children were in puberty when they received RTx, and the mean HAZs were −1.21, −0.68, and −0.28 at 1, 2, and 3 years' postoperatively, respectively. Moreover, 56% of children in puberty exhibited a catch-up growth within the first year after RTx, and this catch-up growth was greater than that of the 24% of children in the second year after RTx and 16% of those in the third year after RTx. The catch-up growth of children in puberty was not statistically significantly different compared to that of children in prepuberty (P > 0.5). In our center, no patients had syndromic diagnoses that affected growth, and children with ESRD did not have previous and current additional enteral nutrition.
| Relationship between growth and age, sex, and history of dialysis
Overall, 45.7% (n = 21/46) of subject's HAZs were less than −2, 8%
(n = 16/46) were between −2 and 0%, and 19.6% (n = 9/46) were more than 0. Therefore, we analyzed the correlation of various factors with the HAZ and found that sex and age at RTx had no correlation with the preoperative HAZ (P > 0.05); however, the duration of dialysis showed a modest negative correlation with the preoperative HAZ. The Pearson correlation coefficient and R 2 value indicated a negative linear correlation between the duration of dialysis and growth.
As shown in Table 2 , the HAZ increased, thereby indicating that growth improved annually. Indeed, 45.7% of children experienced a delay in development preoperatively. Conversely, at 3 years after RTx, only 3.7% of children experienced such a delay. This difference was significant (P = 0.00032). Furthermore, at 3 years'
postoperatively, 48.1% of children exhibited a normal height and rate of development (HAZ > 0). We also found that growth was most accelerated during the first year postoperatively and that the growth rate gradually decreased (P < 0.01). The growth rate between 2 years after RTx and 3 years after RTx was not statistically significant (P = 0.694). Correlation studies showed that the rate of growth within 1 year of RTx was not related to sex or the duration of dialysis (P > 0.05). However, it was negatively correlated with age at RTx (P = 0.134) and the preoperative HAZ (P < 0.001, R 2 = 0.330). These results indicate that a younger age at surgery resulted in a growth lag before rapid growth later in the first year after RTx. Moreover, the growth rate 2 years after RTx was negatively correlated with HAZ before RTx (P = 0.005, R 2 = 0.195), whereas the growth rate 3 years after RTx was unrelated to those variables measured herein.
| Relationship between growth, rhGH, steroid use, and eGFR
There was no statistical significance in the eGFR between the single 
| D ISCUSS I ON
Growth retardation has been one of the greatest risk factors for children with CKD, and it requires rapid treatment. A decrease in height among children with CKD has been shown to be related to malnutrition, anemia, endocrine disorders, renal osteopathy, metabolic acidosis, electrolyte abnormalities, secondary hyperparathyroidism, and the use of glucocorticoids. 8 Usually, we use SD scores or Z-scores to evaluate the growth and development of children. Some studies have shown that the severity of growth retardation was closely related to a child's age. 9 Therefore, some have speculated that per- Therefore, physicians should perform RTx or even preemptive RTx as soon as possible to reduce the effect of dialysis, which could reduce the severity of growth retardation in these patients. Our center adopted the PTP strategy because most children with ESRD in China rely on peritoneal dialysis and the integrity of the peritoneum should be maintained even after RTx in the event of graft failure or delayed graft function. 6 Moreover, an adult donor kidney could not be accommodated for in the limited space of the pediatric iliac fossa.
Hence, the PTP strategy addresses a relentless and progressive shortage of donor kidneys in China and reduces the time required for a donor to be available and to obtain satisfactory results.
FAH is one of the best methods for evaluating children after RTx.
Some previous studies have found that FAH was strongly correlated with baseline height at RTx; however, most children with ESRD could not achieve a final adult height within normal range. [10] [11] [12] This suggests that early intervention can prevent the loss of height and may account for bone age retardation in stunted patients. Addressing this finding may improve the post-RTx growth potential of children.
This improvement in growth was strongly related with the degree of growth retardation before RTx, age at RTx, kidney function, and glucocorticoid use. 1 Nevertheless, with the recognition of pediatric CKD and progression of renal replacement therapy, people have found that nutrition optimization and rhGH use before RTx could resolve growth retardation. 13 Greater efforts to address these fac- 14 This study also demonstrated that performing surgery at an earlier time can improve the recipients' growth.
According to a NAPRTCS report, children aged 0-5 years exhibited a catch-up growth for the initial 1-3 years after RTx, whereas recipients aged 6-12 years exhibited limited improvement or a decrease in HAZ after RTx. Fine et al reported that a catch-up growth was observed in younger patients (6-8 years and 9 years) at 2-3 years after RTx. 15 Nevertheless, our study revealed an opposite result, possibly because of the early withdrawal of glucocorticoids performed at our center. In the present study, we found that 27 children who were older than 6 years experienced growth catch-up at 1 year after RTx.
This was more pronounced in children aged 6 years than in those aged 12 years, which demonstrates that older children could greatly improve their growth after RTx. In addition to age, published data demonstrated that eGFR is another strong predictor of catch-up growth after RTx 16 ; however, we observed no correlation. Qvist et al found that GFR after 5 years of RTx was correlated with the subsequent growth rate from 5 to 7 years after RTx. 17 The mean GFR at 5 years was extremely lower than that of the group without catch-up growth (P = 0.03). Our study did not observe the same results, and this may be because of the higher GFR in our patients.
Because of the deleterious effects of steroid use on growth, careful use of steroids in pediatric recipients is important. 18, 19 Long-term use of corticosteroids causes hypertension, diabetes, Additionally, the nutritional status, donor kidney condition, and race all equally affected the recipients' growth and development.
In our center, we decided to perform early withdrawal of corticosteroids in all children to help them reach FAH. 24 Unfortunately, most Chinese families cannot afford this expensive treatment. To reduce pre-RTx growth impairment and shorten the RTx waiting times for children, our center adopted the PTP allocation strategy.
Although the use of rhGH is not the best for patients with stunted growth, early withdrawal of corticosteroids is needed.
The growth of children in our center after RTx was moderate and accelerated during prepubescence. Early transplant, long-term graft function maintenance, early steroid withdrawal, adequate nutritional support, and improved mineral metabolism are essential to growth.
An increasing number of children with ESRD in China would benefit from such a PTP program, and their quality of life would improve.
Nevertheless, future studies on the long-term outcomes are still needed.
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